₹ 138.44 Cr
1.04%
NIFTY 100 Equal Weight TRI
INF754K01LR3
100.0
100.0
500
Bhavesh Jain, Amit Vora
Fund Performance | 1Y (%) | 3Y (%) | 5Y (%) |
---|---|---|---|
Edelweiss MSCI India Domestic & World Healthcare 45 index Fund Regular Plan - Growth | 40.03 | 13.16 | - |
NIFTY 100 Equal Weight TRI | 50.52 | 20.75 | 21.16 |
Equity
Debt
Others
The scheme seeks to invest in stocks comprising of the MSCI India Domestic & World Healthcare 45 Index with the objective to provide investment returns that, before expenses, closely corresponds to the returns equivalent to the index, subject to tracking errors.
Company | Holdings (%) |
---|---|
Sun Pharmaceutical Industries Ltd. | 13.29 |
Cipla Ltd. | 7.24 |
Dr. Reddy's Laboratories Ltd. | 6.48 |
Apollo Hospitals Enterprise Ltd. | 5.66 |
Max Healthcare Institute Ltd. | 5.6 |
Eli Lilly And Co | 5.26 |
Divi's Laboratories Ltd. | 4.84 |
Novo Nordisk A/S - ADR | 3.51 |
Lupin Ltd. | 3.45 |
Aurobindo Pharma Ltd. | 3.0 |
Sector | Holdings (%) |
---|---|
Healthcare | 99.93 |
Others | 0.07 |